- Home
- LRHC vs ACXP Comparison
LRHC vs ACXP Comparison
Compare LRHC & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRHC
- ACXP
- Stock Information
- Founded
- LRHC 2004
- ACXP 2017
- Country
- LRHC United States
- ACXP United States
- Employees
- LRHC N/A
- ACXP N/A
- Industry
- LRHC
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- LRHC
- ACXP Health Care
- Exchange
- LRHC Nasdaq
- ACXP Nasdaq
- Market Cap
- LRHC 7.3M
- ACXP 6.8M
- IPO Year
- LRHC 2023
- ACXP 2021
- Fundamental
- Price
- LRHC $3.89
- ACXP $5.19
- Analyst Decision
- LRHC
- ACXP Strong Buy
- Analyst Count
- LRHC 0
- ACXP 3
- Target Price
- LRHC N/A
- ACXP $143.67
- AVG Volume (30 Days)
- LRHC 17.3K
- ACXP 90.1K
- Earning Date
- LRHC 11-19-2025
- ACXP 11-12-2025
- Dividend Yield
- LRHC N/A
- ACXP N/A
- EPS Growth
- LRHC N/A
- ACXP N/A
- EPS
- LRHC N/A
- ACXP N/A
- Revenue
- LRHC $78,037,079.00
- ACXP N/A
- Revenue This Year
- LRHC N/A
- ACXP N/A
- Revenue Next Year
- LRHC N/A
- ACXP N/A
- P/E Ratio
- LRHC N/A
- ACXP N/A
- Revenue Growth
- LRHC 54.92
- ACXP N/A
- 52 Week Low
- LRHC $3.66
- ACXP $3.80
- 52 Week High
- LRHC $95.20
- ACXP $37.80
- Technical
- Relative Strength Index (RSI)
- LRHC 35.23
- ACXP 43.61
- Support Level
- LRHC $3.66
- ACXP $4.51
- Resistance Level
- LRHC $4.41
- ACXP $5.79
- Average True Range (ATR)
- LRHC 0.46
- ACXP 0.54
- MACD
- LRHC -0.13
- ACXP -0.14
- Stochastic Oscillator
- LRHC 21.92
- ACXP 20.52
About LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.